{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:46:08Z","timestamp":1791351968595,"version":"4.3.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,9]]},"DOI":"10.1212\/wnl.47.3.690","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:23:00Z","timestamp":1336915380000},"page":"690-695","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":65,"title":["Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France"],"prefix":"10.1212","volume":"47","author":[{"given":"T. Billette","family":"de Villemeur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-P.","family":"Deslys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pradel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Soubrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alperovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tardieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-L.","family":"Chaussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-J.","family":"Hauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dormont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ruberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Agid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350103"},{"key":"e_1_3_1_3_2","first-page":"3","volume":"161","year":"1968","unstructured":"Gibbs CJ, Gajdusek DC, Asher DM, et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to chimpanzee. Science 1968;161:389-390.","journal-title":"Science"},{"key":"e_1_3_1_4_2","first-page":"2","volume":"340","year":"1992","unstructured":"Brown P, Preece MA, Will RG. `Friendly fire' in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992;340:24-27.","journal-title":"Lancet"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197401032900102"},{"key":"e_1_3_1_6_2","first-page":"7","volume":"69","year":"1988","unstructured":"Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft: case report. J Neurosurg 1988;69:766-769.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_7_2","first-page":"1","volume":"261","year":"1989","unstructured":"Nisbet TJ, McDonaldson I, Bishara SN. Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. JAMA 1989;261:11-18.","journal-title":"JAMA"},{"key":"e_1_3_1_8_2","first-page":"9","volume":"71","year":"1989","unstructured":"Masullo C, Pocchiari M, Macchi G, Alema G, Piazza G, Panzera MA. Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg 1989;71:954-955.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_9_2","first-page":"9","volume":"41","year":"1991","unstructured":"Miyashita K, Inuzuka T, Kondo H, et al. Creutzfeldt-Jakob disease in a patient with a cadaveric dural graft. Neurology 1991;41:940-941.","journal-title":"Neurology"},{"key":"e_1_3_1_10_2","first-page":"9","volume":"54","year":"1991","unstructured":"Willison HJ, Gale HN, McLaughlin JE. Creutzfeldt-Jakob disease following cadaveric dura mater graft [letter]. J Neurol Neurosurg Psychiatry 1991;54:940.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_11_2","first-page":"6","volume":"340","year":"1992","unstructured":"Pocchiari M, Masullo C, Salvatore M, Genuardi M, Galgani S. Creutzfeldt-Jakob disease after non-commercial dura mater graft. Lancet 1992;340:614-615.","journal-title":"Lancet"},{"key":"e_1_3_1_12_2","first-page":"9","volume":"56","year":"1993","unstructured":"Esmonde T, Lueck CJ, Symon L, Ducken LW, Will RG. Creutzfeldt-Jakob disease and lyophilized dura mater grafts: report of two cases. J Neurol Neurosurg Psychiatry 1993;56:999-1000.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.Suppl.1"},{"key":"e_1_3_1_14_2","first-page":"1","volume":"21","year":"1993","unstructured":"Takayama S, Hatsuda N, Matsumura K, Nakasu S, Handa J. Creutzfeldt-Jakob disease transmitted by cadaveric dural graft: a case report. No Shinkei Geka 1993;21:167-170.","journal-title":"No Shinkei Geka"},{"key":"e_1_3_1_15_2","first-page":"7","volume":"34","year":"1994","unstructured":"Lane KL, Brown P, Howell DN, et al. Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery 1994;34:737-740.","journal-title":"Neurosurgery"},{"key":"e_1_3_1_16_2","first-page":"7","volume":"34","year":"1994","unstructured":"Yamada S, Aiba T, Endo Y, Hara M, Kitamoto T, Tateishi J. Creutzfeldt-Jakob disease transmitted by a cadaveric dura mater graft. Neurosurgery 1994;34:740-744.","journal-title":"Neurosurgery"},{"key":"e_1_3_1_17_2","first-page":"2","volume":"2","year":"1985","unstructured":"Powell-Jackson J, Weller RO, Kennedy P, Preece MA, Whitcombe EM, Newsom-Davis J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 1985;2:244-246.","journal-title":"Lancet"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507043130102"},{"key":"e_1_3_1_19_2","first-page":"7","volume":"313","year":"1985","unstructured":"Gibbs CJ, Joy A, Heffner R, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone? N Engl J Med 1985;313:734-738.","journal-title":"Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone? N Engl J Med"},{"key":"e_1_3_1_20_2","first-page":"9","volume":"36","year":"1986","unstructured":"Tintner R, Brown P, Hedley-Whyte T, Rappaport EB, Piccardo CP, Gajdusek DC. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenic implications? Neurology 1986;36:932-936.","journal-title":"Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenic implications? Neurology"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.1.1"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.1.1"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.1.1"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.302.6767.1"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460010006001"},{"key":"e_1_3_1_26_2","first-page":"8","volume":"302","year":"1991","unstructured":"Buchanan CR, Preece MA, Milner RDG. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ 1991;302:824-828.","journal-title":"BMJ"},{"key":"e_1_3_1_27_2","first-page":"8","volume":"337","year":"1991","unstructured":"Billette de Villemeur T, Beauvais P, Gourmelen M, Richardet JM. Creutzfeldt-Jakob disease in children treated with growth hormone. Lancet 1991;337:864-865.","journal-title":"Lancet"},{"key":"e_1_3_1_28_2","first-page":"3","volume":"148","year":"1992","unstructured":"Billette de Villemeur T, Gourmelen M, Beauvais P, et al. Maladie de Creutzfeldt-Jakob chez quatre enfants traites par hormone de croissance. Rev Neurol (Paris) 1992;148:328-334.","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_3_1_29_2","first-page":"5","volume":"149","year":"1993","unstructured":"Delisle MB, Fabre N, Rochiccioli P, Doerr-Schott J, Rumeau JL, Bes A. Maladie de Creutzfeldt-Jakob apres traitement par l'hormone de croissance extractive humaine: etude clinicopathologique. Rev Neurol (Paris) 1993;149:524-527.","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_3_1_30_2","first-page":"4","volume":"43","year":"1993","unstructured":"Labauge P, Pages M, Blard JM, Chatelain J, Laplanche JL. Valine homozygous 129 PrP genotype in a French growth-hormone-related Creutzfeldt-Jakob disease patient [letter]. Neurology 1993;43:447.","journal-title":"Neurology"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.1994.tb00949.x"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.1.1"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","unstructured":"Job JC Maillard F Goujard J. Epidemiologic survey of patients treated with growth hormone in France in the period 1959-1990: preliminary results. Horm Res 1992;38(suppl 1):35-43.","DOI":"10.1159\/000182568"},{"key":"e_1_3_1_34_2","first-page":"5","volume":"314","year":"1986","unstructured":"Brown P, Coker-Vann M, Franko M, Asher DM, Gibbs CJ, Gajdusek DC. Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med 1986;314:547-551.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_35_2","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed: DSM-IV. Washington DC: American Psychiatric Association 1994."},{"key":"e_1_3_1_36_2","first-page":"3","volume":"43","year":"1994","unstructured":"Deslys JP, Lasmezas C, Dormont D. Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease. Lancet 1994;43:3848-3849.","journal-title":"Lancet"},{"key":"e_1_3_1_37_2","first-page":"4","volume":"6","year":"1979","unstructured":"Brown P, Cathala F, Sadowsky D, Gajdusek DC. Creutzfeldt-Jakob disease in France. II. Clinical characteristics of 124 consecutive verified cases during the decade 1968-1977. Ann Neurol 1979;6:430-437.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_38_2","first-page":"1","volume":"346","year":"1995","unstructured":"Bateman D, Hilton D, Love S, Zeidler M, Beck J, Collinge J. Sporadic Creutzfeldt-Jakob disease in an 18-year-old in the UK. Lancet 1995;346:1155-1156.","journal-title":"Lancet"},{"key":"e_1_3_1_39_2","first-page":"1","volume":"346","year":"1995","unstructured":"Britton TC, Al-Sarraj S, Shaw C, Gajdusek DC, Campbell T, Collinge J. Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet 1995;346:1155.","journal-title":"Lancet"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350104"},{"key":"e_1_3_1_41_2","first-page":"2","volume":"91","year":"1994","unstructured":"Monari L, Chen SG, Brown P, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 1994;91:2839-2842.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_42_2","first-page":"8","volume":"37","year":"1987","unstructured":"Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of world literature. Neurology 1987;37:895-904.","journal-title":"Neurology"},{"key":"e_1_3_1_43_2","first-page":"1","volume":"78","year":"1994","unstructured":"Frasier SD, Foley TP. Creutzfeldt-Jakob disease in recipients of pituitary hormones. J Clin Endocrinol Metab 1994;78:1277-1279.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91043-X"},{"key":"e_1_3_1_45_2","first-page":"2","volume":"75","year":"1994","unstructured":"Deslys JP, Marce D, Dormont D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol 1994;75:23-27.","journal-title":"J Gen Virol"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93327-6"},{"key":"e_1_3_1_47_2","first-page":"2","volume":"78","year":"1968","unstructured":"Dickinson AG, Meikle VMH, Fraser H. Identification of a gene which controls the incubation period of same strains of scrapie agent in mice. J Comp Pathol 1968;78:293-299.","journal-title":"J Comp Pathol"},{"key":"e_1_3_1_48_2","first-page":"7","volume":"83","year":"1995","unstructured":"Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995;83:79-90.","journal-title":"Cell"},{"key":"e_1_3_1_49_2","first-page":"5","volume":"149","year":"1993","unstructured":"Anonyme. La maladie de Creutzfeldt-Jakob iatrogene provoquee par l'administration d'hormone de croissance extractive [editorial]. Rev Neurol (Paris) 1993;149:515-516.","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_3_1_50_2","first-page":"1","volume":"41","year":"1995","unstructured":"Billette de Villemeur T, Agid Y. La maladie de Creutzfeldt-Jakob iatrogene: Quelles sont les precautions a prendre pour prevenir la contamination neurochirurgicale [editorial]? Neurochir 1995;41:1-2.","journal-title":"La maladie de Creutzfeldt-Jakob iatrogene: Quelles sont les precautions a prendre pour prevenir la contamination neurochirurgicale [editorial]? Neurochir"},{"key":"e_1_3_1_51_2","first-page":"3","volume":"22","year":"1994","unstructured":"McGreevy Steelman V. Creutzfeldt-Jakob disease: recommendations for infection control. Am J Infect Control 1994;22:312-318.","journal-title":"Am J Infect Control"},{"key":"e_1_3_1_52_2","first-page":"1","volume":"345","year":"1995","unstructured":"Farrington M. Use of surgical instruments in Creutzfeldt-Jakob disease. Lancet 1995;345:194.","journal-title":"Lancet"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.3.690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:14:56Z","timestamp":1711534496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.3.690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,9]]}},"alternative-id":["10.1212\/WNL.47.3.690"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.3.690","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,9]]}}}